Borlongan LAZ, Samante FLD, Ontingco AJM, Tilbe JPA, et al. Impact of luseogliflozin on metabolic health, lipid profiles, and cardiovascular outcomes in patients with type II diabetes: A systematic review and network meta-analysis. Diabetes Obes Metab 2026 Jan 25. doi: 10.1111/dom.70482.
PMID: 41582558